Deerfield Management’s Loxo Oncology, Inc LOXO Stock Holding History

Deerfield Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-169,000	Closed	-$14.2M	–	132
2017 Q4	$14.2M	Hold	169,000	–	–	0.56%	57
2017 Q3	$15.6M	Sell	169,000 -82,167	-33%	-$6.38M	0.7%	47
2017 Q2	$20.1M	Sell	251,167 -502,133	-67%	-$27.8M	1.07%	29
2017 Q1	$31.7M	Buy	753,300 +502,300	+200%	+$20.7M	1.22%	32
2016 Q4	$8.06M	Hold	251,000	–	–	0.33%	65
2016 Q3	$6.57M	Hold	251,000	–	–	0.31%	54
2016 Q2	$5.82M	Hold	251,000	–	–	0.23%	69
2016 Q1	$6.86M	Hold	251,000	–	–	0.29%	64
2015 Q4	$7.14M	Sell	251,000 -837,225	-77%	-$22.5M	0.29%	71
2015 Q3	$19M	Sell	1,088,225 -361,926	-25%	-$7.08M	0.74%	51
2015 Q2	$26.1M	Sell	1,450,151 -141,395	-9%	-$1.93M	0.87%	42
2015 Q1	$19.8M	Hold	1,591,546	–	–	0.64%	40
2014 Q4	$18.7M	Hold	1,591,546	–	–	0.67%	41
2014 Q3	$20.9M	Buy	+1,591,546	New	+$20.6M	0.76%	47

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management's LOXO Position: Q1 2018 in Review

Deerfield Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2018, closing a stake of 169,000 shares — an estimated $14.2M sold.

Deerfield Management first reported a position in LOXO in Q3 2014 and held it in 14 quarters. The position peaked at $31.7M in Q1 2017. 158 funds tracked by Wall St. Rank hold LOXO as of Q1 2018.

Deerfield Management reported no remaining Loxo Oncology, Inc position as of Q1 2018 after selling out during the quarter.
Deerfield Management sold 169,000 Loxo Oncology, Inc shares in Q1 2018, an estimated $14.2M.
Deerfield Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 14 quarters.
Deerfield Management's Loxo Oncology, Inc position peaked at $31.7M in Q1 2017.
158 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2018.

Based on Deerfield Management's 13F filing for Q1 2018, filed 15 May 2018.